Related references
Note: Only part of the references are listed.Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor-Negative Mammary Carcinogenesis in Polyoma Middle T Mice
Kim Tran et al.
CANCER PREVENTION RESEARCH (2012)
Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin
Michael A. Pereira et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease
Karen T. Liby et al.
PHARMACOLOGICAL REVIEWS (2012)
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
P. N. Munster et al.
BRITISH JOURNAL OF CANCER (2011)
Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining
Carol DeSantis et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Tumor Microenvironment and Progression
Harold F. Dvorak et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Effects and Mechanisms of the Combination of Suberoylanilide Hydroxamic Acid and Bortezomib on the Anticancer Property of Gemcitabine in Pancreatic Cancer
Jun Kyu Lee et al.
PANCREAS (2011)
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines
Andrea Morandi et al.
PLOS ONE (2011)
Suberoylanilide Hydroxamic Acid Blocks Self-Renewal and Homotypic Aggregation of Inflammatory Breast Cancer Spheroids
Fredika M. Robertson et al.
CANCER (2010)
Deploying Mouse Models of Pancreatic Cancer for Chemoprevention Studies
Paul J. Grippo et al.
CANCER PREVENTION RESEARCH (2010)
Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
Karen T. Liby et al.
CANCER PREVENTION RESEARCH (2010)
Anti-inflammatory Agents: Present and Future
Charles A. Dinarello
CELL (2010)
Cancer and Inflammation: Implications for Pharmacology and Therapeutics
F. Balkwill et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
Evette S. Radisky et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
A comprehensive catalogue of somatic mutations from a human cancer genome
Erin D. Pleasance et al.
NATURE (2010)
Triterpenoids CDDO-Methyl Ester or CDDO-Ethyl Amide and Rexinoids LG100268 or NRX194204 for Prevention and Treatment of Lung Cancer in Mice
Karen Liby et al.
CANCER PREVENTION RESEARCH (2009)
Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor
Antonia Patsialou et al.
CANCER RESEARCH (2009)
Colony-Stimulating Factor-1 Receptor Inhibitors for the Treatment of Cancer and Inflammatory Disease
Sharmila Patel et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Histone Deacetylase Inhibitors in Cancer Therapy
Andrew A. Lane et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Trophic macrophages in development and disease
Jeffrey W. Pollard
NATURE REVIEWS IMMUNOLOGY (2009)
Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy
Mayumi Ono
CANCER SCIENCE (2008)
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl ester and the rexinoid LG100268
Karen Liby et al.
CLINICAL CANCER RESEARCH (2008)
Macrophages define the invasive microenvironment in breast cancer
Jeffrey W. Pollard
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model
Kasper Almholt et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Colony-stimulating factors in inflammation and autoimmunity
John A. Hamilton
NATURE REVIEWS IMMUNOLOGY (2008)
Metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer
Carlo V. Hojilla et al.
BREAST CANCER RESEARCH (2008)
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent
Nicola Vannini et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Breast cancer progression: insights into multifaceted matrix metalloproteinases
Vincent Chabottaux et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
A new rexinoid, NRX194204, prevents carcinogenesis in both the lung and mammary gland
Karen Liby et al.
CLINICAL CANCER RESEARCH (2007)
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Carolyn E. Clark et al.
CANCER RESEARCH (2007)
Tumor-associated macrophages press the angiogenic switch in breast cancer
Elaine Y. Lin et al.
CANCER RESEARCH (2007)
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Karen T. Liby et al.
NATURE REVIEWS CANCER (2007)
The decrease in breast-cancer incidence in 2003 in the United States.
Peter M. Ravdin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice
Karen Liby et al.
CANCER RESEARCH (2007)
The tumour microenvironment as a target for chemoprevention
Adriana Albini et al.
NATURE REVIEWS CANCER (2007)
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer
Nichole Boyer Arnold et al.
CLINICAL CANCER RESEARCH (2007)
Macrophages regulate the angiogenic switch in a mouse model of breast cancer
Elaine Y. Lin et al.
CANCER RESEARCH (2006)
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Yunping Luo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A synthetic triterpenoid, CDDO-Me, inhibits IκBα, kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor κB-regulated gene products in human leukemic cells
S Shishodia et al.
CLINICAL CANCER RESEARCH (2006)
Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells
M Konopleva et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The multifaceted roles of chemokines in malignancy
A. Ben-Baruch
CANCER AND METASTASIS REVIEWS (2006)
A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells
LK Gediya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis
E Giraudo et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases
EY Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production
T Honda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines
F Leoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling
CF Deroanne et al.
ONCOGENE (2002)
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
L Bingle et al.
JOURNAL OF PATHOLOGY (2002)
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
EY Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Synthetic oleanane and ursane triterpenoids with modified rings A and C: A series of highly active inhibitors of nitric oxide production in mouse macrophages
T Honda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
